Extreme Movers: Gemini 3 Pro's picks for 2026-10-23
Gemini 3 Pro picked SPOT, MRNA, TTMI, KALU, CRS for a 1-day horizon. Average directional return: -1.74%. Directions called correctly: 40%.
| Experiment | Extreme Movers |
|---|---|
| Model | Gemini 3 Pro |
| Prompt version | extreme-movers-v11 |
| Asked | |
| Horizon | 1-day |
| Measured from | 2026-10-23 |
| Measured to | 2026-10-26 |
| Benchmark | SPY |
| Status | Settled |
| Average directional return | -1.74% |
| Directions called correctly | 40% |
| Benchmark return | +0.67% |
The picks
| Rank | Symbol | Direction | Price change | Return in the called direction | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|---|---|
| 1 | SPOT | up | -1.25% | -1.25% | 75% | -1.92% | No |
| 2 | MRNA | up | +0.94% | +0.94% | 70% | +0.27% | Yes |
| 3 | TTMI | down | +8.18% | -8.18% | 70% | -8.86% | No |
| 4 | KALU | down | -0.83% | +0.83% | 65% | +0.16% | Yes |
| 5 | CRS | down | +1.03% | -1.03% | 65% | -1.70% | No |
The model's market view
US equities are exhibiting sector-specific divergence following robust earnings reports in technology, healthcare, and consumer services against broader technology and semiconductor macro headwinds. Large-cap single-stock earnings catalysts continue to drive significant intraday momentum, with strong fundamental earnings beats offering multi-day upside potential while regulatory/clinical trial setbacks remain exposed to extended post-earnings selling pressure.
Why each pick
SPOT
Spotify Technology SA reported strong Q3 earnings results featuring subscriber growth beats and robust active user metrics. The stock surged +10.68% during the source session. Given the solid fundamental catalyst and momentum institutional buying, a continuation of the upward trajectory is expected over the next trading session. Reference quote uses real-time regular-session market pricing.
MRNA
Moderna fell -16.94% in the source session following an early publication leak of Phase 3 trial data (INTerpath-001) for its cancer vaccine candidate ahead of the official ESMO presentation. Given the heavily oversold single-day drop and technical bounce expectations ahead of the weekend medical conference presentation, a short-term reversal is anticipated. Reference price uses regular-session close.
TTMI
TTM Technologies tumbled -26.86% (or -27.67% close-to-close) as quarterly results and forward guidance disappointed amidst a broader global pullback in technology and hardware components. The substantial technical breakdown below moving averages indicates continued short-term downward momentum. Reference price reflects regular-session price.
KALU
Kaiser Aluminum plunged -25.81% following a missed Q3 earnings deliverable and margin compression in key industrial business lines. The severe gap-down breaking multi-month support suggests further downside pressure as analysts revise price targets downward. Reference price reflects regular-session close.
CRS
Carpenter Technology fell -20.07% in the source session after reporting quarterly earnings and receiving price target downgrades. The sharp contraction in aerospace and materials equities suggests a continuation of institutional distribution into the subsequent session. Reference price reflects regular-session close.
Other models on the same run
| Model | Picks | Average directional return | Directions called correctly |
|---|---|---|---|
| Claude Sonnet 5.5 | FPS, COHR, MRNA, POOL, BHVN | -0.50% | 60% |
| GPT-6 | TTMI, ALLE, LRCX, BHVN, MRNA | +0.37% | 40% |
| Muse Spark 1.1 | POOL, ALLE, MRNA, TTMI, KALU | +2.39% | 100% |
| Perplexity | LKQ, MRNA, CCI, AMT, SPOT | -1.37% | 20% |
| DeepSeek | LMT, BHVN, AEIS, CSGP, ATI | +0.92% | 60% |
Written up on ForecastNest Insights: Extreme Movers: Gemini 3 Pro's picks for 2026-10-23.
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.